Fråga Google

You searched for: pharmacodynamic (Franska - Finska)

Mänskliga bidrag

Från professionella översättare, företag, webbsidor och fritt tillgängliga översättningsdatabaser.

Lägg till en översättning

Franska

Finska

Info

Franska

Pharmacokinetics and Pharmacodynamics in patients with Impaired renal function: study design, data analysis, and impact on dosing and labelling (pharmacocinétique et la pharmacodynamique chez les patients dont la fonction rénale est altérée: conception de l’ étude, analyse des données et impact sur la posologie et l’ étiquetage).

Finska

Tuolloin, vuonna 1989, munuaisten vajaatoiminnan eri tasojen cut- off- arvot noudattivat FDA: n alalle laatimaa ohjeluonnosta "Pharmacokinetics and Pharmacodynamics in patients with Impaired renal function: study design, data analysis, and impact on dosing and labelling".

Senast uppdaterad: 2011-10-23
Användningsfrekvens: 1
Kvalitet:

Varning: Innehåller osynlig HTML-formatering
Varning: Denna återanvändning kan vara fel.
Vänligen ta bort den om du anser det.

Franska

Note for Guidance on Clinical Investigation of Medical Products in the Treatment of Obsessive-compulsive Disorder Addendum on acute cardiac failure to the CPMP Note for Guidance on clinical investigation of medicinal products in the treatment of acute cardiac failure Note for guidance on the evaluation of medicinal products for the treatment of dyslipoproteinaemia Note for Guidance on Clinical investigation of steroid contraceptives in women Revision of Note for Guidance on evaluation of new anti-bacterial medicinal products (CPMP/ EWP/ 558/ 95) and Note for Guidance on the pharmacodynamic section of the summary of product characteristics for antibacterial medicinal products

Finska

Note for Guidance on Clinical Investigation of Medical Products in the Treatment of Obsessive- compulsive Disorder Addendum on acute cardiac failure to the CPMP Note for Guidance on clinical investigation of medicinal products in the treatment of acute cardiac failure Note for guidance on the evaluation of medicinal products for the treatment of dyslipoproteinaemia Note for Guidance on Clinical investigation of steroid contraceptives in women Revision of Note for Guidance on evaluation of new anti- bacterial medicinal products (CPMP/ EWP/ 558/ 95) and Note for Guidance on the pharmacodynamic section of the summary of product characteristics for antibacterial medicinal products

Senast uppdaterad: 2011-10-23
Användningsfrekvens: 1
Kvalitet:

Varning: Denna återanvändning kan vara fel.
Vänligen ta bort den om du anser det.

Franska

Titre du document Note for guidance on clinical investigation of medicinal products for the treatment of diabetes mellitus Note for guidance on clinical investigation of anti-depressive agents Note for guidance on clinical investigation of medicinal products for pain treatment Position paper on new modified formulations of acetyl salicylic acid in the secondary prevention of cardiovascular events Note for guidance on clinical investigation of medicinal products for treatment of peripheral arterial occlusive disease Concept paper on the revision of the Note for guidance on evaluation of new anti-bacterial medicinal product (CPMP/ EWP/ 558/ 95) and the Note for guidance on the pharmacodynamic section of the summary of product characteristics for antibacterial products Points to consider on biostatistical/ methodological issues arising from CPMP discussion on licensing applications:

Finska

Asiakirjan nimi Note for guidance on clinical investigation of medicinal products for the treatment of diabetes mellitus Note for guidance on clinical investigation of anti- depressive agents Note for guidance on clinical investigation of medicinal products for pain treatment Position paper on new modified formulations of acetyl salicylic acid in the secondary prevention of cardiovascular events Note for guidance on clinical investigation of medicinal products for treatment of peripheral arterial occlusive disease Concept paper on the revision of the Note for guidance on evaluation of new anti- bacterial medicinal product (CPMP/ EWP/ 558/ 95) and the Note for guidance on the pharmacodynamic section of the summary of product characteristics for antibacterial products Points to consider on biostatistical/ methodological issues arising from CPMP discussion on licensing applications:

Senast uppdaterad: 2011-10-23
Användningsfrekvens: 1
Kvalitet:

Varning: Denna återanvändning kan vara fel.
Vänligen ta bort den om du anser det.

Franska

Pharmacokinetics and pharmacodynamics in the Transmis pour consultation en décembre 1999 development of antibacterial medicinal products

Finska

Biostatistical/ methodological issues:

Senast uppdaterad: 2011-10-23
Användningsfrekvens: 1
Kvalitet:

Varning: Denna återanvändning kan vara fel.
Vänligen ta bort den om du anser det.

Franska

Titre du document Concept paper for the development of the revision of the CPMP Note for Guidance on evaluation of new anti- bacterial medicinal products (CPMP/ EWP/ 558/ 95) and the CPMP Note for Guidance on the pharmacodynamic section of the SPC for anti-bacterial medicinal products (CPMP/ EWP/ 520/ 96)

Finska

Asiakirjan nimi Concept paper for the development of the revision of the CPMP Note for Guidance on evaluation of new anti - bacterial medicinal products (CPMP/ EWP/ 558/ 95) and the CPMP Note for Guidance on the pharmacodynamic section of the SPC for anti- bacterial medicinal products (CPMP/ EWP/ 520/ 96)

Senast uppdaterad: 2011-10-23
Användningsfrekvens: 1
Kvalitet:

Varning: Denna återanvändning kan vara fel.
Vänligen ta bort den om du anser det.

Få en bättre översättning med
4,401,923,520 mänskliga bidrag

Användare ber nu om hjälp:



Vi använder cookies för att förbättra din upplevelse. Genom att fortsätta besöka den här webbplatsen godkänner du vår användning av cookies. Läs mer. OK